(Rac) -Byakangelicin
(Rac) -Byakangelicin is a synthetic furanocoumarin derivative with antineoplastic properties. It has been investigated in vitro for its potential anti-cancer effects, showing activity in various cellular models relevant to oncology research.
Product Specifications
CAS Number
19573-01-4
Product Name Alternative
7H-Furo[3,2-g][1]benzopyran-7-one, 9- (2,3-dihydroxy-3-methylbutoxy) -4-methoxy-, aldose-reductase, (Rac) Byakangelicin, (Rac) Byakangelicin, (Rac) -Byakangelicin, Byakangelicin, Biacangelicin, Bjacangelicin, Bjakangelicin, inhibit, Inhibitor, racemate
Field of Research
Signal Transduction
Purity
98.74% (May vary between batches)
Solubility
DMSO:25 mg/mL (74.78 mM) ;10% DMSO+90% Corn Oil:2 mg/mL (5.98 mM)
Smiles
COc1c2ccoc2c (OCC (O) C (C) (C) O) c2oc (=O) ccc12
Molecular Formula
C17H18O7
Molecular Weight
334.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog